Late Breaking Abstract - Clinical utility of basophil activating test (BAT) in subjects with drug-induced lung disease.

S. Suzuki (Tokyo, Japan), T. Homma (Tokyo, Japan), S. Ohta (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), Y. Miyata (Tokyo, Japan), Y. Kishino (Tokyo, Japan), A. Tanaka (Tokyo, Japan), T. Ohnishi (Tokyo, Japan), H. Sagara (Tokyo, Japan)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management

Session: CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Session type: Oral Presentation
Number: 3815

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Suzuki (Tokyo, Japan), T. Homma (Tokyo, Japan), S. Ohta (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), Y. Miyata (Tokyo, Japan), Y. Kishino (Tokyo, Japan), A. Tanaka (Tokyo, Japan), T. Ohnishi (Tokyo, Japan), H. Sagara (Tokyo, Japan). Late Breaking Abstract - Clinical utility of basophil activating test (BAT) in subjects with drug-induced lung disease.. 3815

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017
Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021
Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021
Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020
Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS) Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019
Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017
Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Late Breaking Abstract - Long-term variability of blood eosinophils in COPD patients by GOLD 2017 staging, and gender bias Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014
Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014
Clinical and pathophysiological features of asthma phenotypes Source: Annual Congress 2013 –Asthma at the bedside Year: 2013
Late Breaking Abstract - Prediction of chronic lung allograft rejection (CLAD) by measurement of peripheral T cells linked to the inhibitory check-point HLA-G. Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Features of clinical and functional parameters of ACOS-syndrome Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016